Some users may experience side effects such as nausea, fatigue, or gastrointestinal discomfort, especially when starting GLP-1 medications or oral kits
for semaglutide, liraglutide and dulaglutide, no dose adjustment is generally required, but monitor in severe renal impairment, especially with gastrointestinal losses Pregnancy and breastfeeding: GLP-1 therapies are not recommended during pregnancy
*Journal of Pharmacological and Toxicological Methods*, 70(1), 1-17
The melanotan-1 dosage protocol begins with 0.25mg daily for 5 days to assess tolerance before escalating to 0.51.0mg maintenance dose for 1421 days total
Resuspended samples were loaded onto equilibrated spin columns (2000 g , 2 min), passing the entire sample twice through the column
All experiments were repeated three times